[In recent clinical trials, engineered CAR T cells have yielded response rates as high as 90% in patients with leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE